title: Refining the association of MHC with multiple sclerosis in African Americans.
abstract: Multiple sclerosis (MS) is a common demyelinating disease of the central nervous system mediated by autoimmune and neurodegenerative pathogenic mechanisms. Multiple genes account for its moderate heritability, but the only genetic region shown to have a large replicable effect on MS susceptibility is the major histocompatibility complex (MHC). Strong linkage disequilibrium (LD) across the MHC has made it difficult to fully characterize individual genetic contributions of this region to MS risk in previous studies. African Americans are at a lower risk for MS when compared with northern Europeans and Americans of European descent, but greater haplotypic diversity and distinct patterns of LD suggest that this population may be particularly informative for fine-mapping efforts. To examine the role of the MHC in African American MS, a case-control association study was performed with 499 African American MS patients and 750 African American controls that were genotyped for 6040 MHC region single nucleotide polymorphisms (SNPs). A replication data set consisting of 451 African American patients and 718 African American controls was genotyped for selected SNPs. Two MHC class II SNPs, rs2647040 and rs3135021, were significant in the replication cohort and partially tagged DRB1*15 alleles. Surprisingly, in comparison to similar studies of individuals of European descent, the MHC seems to play a smaller role in MS susceptibility in African Americans, consistent with pervasive genetic heterogeneity across ancestral groups, and may explain the difference in MS susceptibility between African Americans and individuals of European descent.
authors.affiliation: Department of Neurology, University of California, San Francisco, CA 94143, USA. joseph.mcelroy@ucsf.edu
authors.forename: Joseph P
authors.initials: JP
authors.lastname: McElroy
authors.forename: Bruce A C
authors.initials: BA
authors.lastname: Cree
authors.forename: Stacy J
authors.initials: SJ
authors.lastname: Caillier
authors.forename: Peter K
authors.initials: PK
authors.lastname: Gregersen
authors.forename: Joseph
authors.initials: J
authors.lastname: Herbert
authors.forename: Omar A
authors.initials: OA
authors.lastname: Khan
authors.forename: Jan
authors.initials: J
authors.lastname: Freudenberg
authors.forename: Annette
authors.initials: A
authors.lastname: Lee
authors.forename: S Louis
authors.initials: SL
authors.lastname: Bridges
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Hauser
authors.forename: Jorge R
authors.initials: JR
authors.lastname: Oksenberg
authors.forename: Pierre-Antoine
authors.initials: PA
authors.lastname: Gourraud
mesh_terms: D000328:Adult; D001741:Black or African American / Q000235:genetics*; D000483:Alleles; D015331:Cohort Studies; D020022:Genetic Predisposition to Disease; D005828:Genetics, Population; D006684:HLA-DR Antigens / Q000235:genetics; D059811:HLA-DRB1 Chains; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D015810:Linkage Disequilibrium / Q000235:genetics; D008285:Major Histocompatibility Complex / Q000235:genetics*; D009103:Multiple Sclerosis / Q000235:genetics* / Q000276:immunology*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D015203:Reproducibility of Results
chemical_list: D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains
references.citation: Curr Top Microbiol Immunol. 2008;318:45-72
references.pmid: 18219814
references.citation: Neurology. 2006 Apr 25;66(8):1235-40
references.pmid: 16636241
references.citation: PLoS One. 2008;3(10):e3490
references.pmid: 18941528
references.citation: J Immunol. 2008 Oct 15;181(8):5473-80
references.pmid: 18832704
references.citation: Bioinformatics. 2005 Jan 15;21(2):263-5
references.pmid: 15297300
references.citation: Am J Hum Genet. 2004 Jan;74(1):160-7
references.pmid: 14669136
references.citation: Ann Neurol. 2000 Dec;48(6):927-31
references.pmid: 11117550
references.citation: Curr Neurol Neurosci Rep. 2008 Sep;8(5):427-33
references.pmid: 18713580
references.citation: PLoS Genet. 2008 Jan;4(1):e4
references.pmid: 18208329
references.citation: Nature. 1995 Sep 14;377(6545):150-1
references.pmid: 7675080
references.citation: Nat Rev Genet. 2008 Jul;9(7):516-26
references.pmid: 18542080
references.citation: Neuron. 2006 Oct 5;52(1):61-76
references.pmid: 17015227
references.citation: Nat Genet. 2009 Jul;41(7):824-8
references.pmid: 19525955
references.citation: Arch Neurol. 2009 Feb;66(2):226-33
references.pmid: 19204159
references.citation: Lancet. 1976 Dec 11;2(7998):1261-5
references.pmid: 63743
references.citation: Nucleic Acids Res. 2001 Jan 1;29(1):308-11
references.pmid: 11125122
references.citation: Am J Hum Genet. 2008 Jan;82(1):48-56
references.pmid: 18179884
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18680-5
references.pmid: 19846760
references.citation: Lancet Neurol. 2003 Feb;2(2):117-27
references.pmid: 12849268
references.citation: Tissue Antigens. 1991 Jul;38(1):1-15
references.pmid: 1926129
references.citation: Hum Mol Genet. 2008 Oct 15;17(R2):R143-50
references.pmid: 18852203
references.citation: Genes Immun. 2008 Oct;9(7):624-30
references.pmid: 18650830
references.citation: Ann Neurol. 2001 Jul;50(1):121-7
references.pmid: 11456302
references.citation: Neurology. 2004 Dec 14;63(11):2039-45
references.pmid: 15596747
references.citation: Hum Mol Genet. 2009 Feb 15;18(4):767-78
references.pmid: 19010793
references.citation: J Immunol. 2009 Sep 1;183(5):3531-41
references.pmid: 19648275
references.citation: Nat Genet. 2009 Jul;41(7):776-82
references.pmid: 19525953
references.citation: Eur J Hum Genet. 2004 Oct;12(10):805-12
references.pmid: 15252420
references.citation: Mult Scler. 2009 Jun;15(6):661-7
references.pmid: 19482860
references.citation: Nat Genet. 2006 Nov;38(11):1298-303
references.pmid: 17057720
references.citation: Brain. 1996 Apr;119 ( Pt 2):449-55
references.pmid: 8800940
references.citation: Arthritis Rheum. 2008 Aug;58(8):2275-86
references.pmid: 18668548
references.citation: Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S138-45
references.pmid: 14969066
references.citation: J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):329-33
references.pmid: 9120443
references.citation: Mult Scler. 2009 Dec;15(12):1422-30
references.pmid: 19965521
references.citation: J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80
references.pmid: 3450848
references.citation: Mult Scler. 2003 Jun;9(3):293-8
references.pmid: 12814178
references.citation: Curr Opin Neurol Neurosurg. 1993 Apr;6(2):189-94
references.pmid: 8481562
references.citation: Lancet. 1996 Jun 22;347(9017):1728-30
references.pmid: 8656905
references.citation: N Engl J Med. 2007 Aug 30;357(9):851-62
references.pmid: 17660530
references.citation: Genome Res. 2004 Jun;14(6):1176-87
references.pmid: 15140828
references.citation: Nat Genet. 2006 Oct;38(10):1166-72
references.pmid: 16998491
references.citation: Nature. 2003 Dec 18;426(6968):789-96
references.pmid: 14685227
references.citation: Tissue Antigens. 2007 Apr;69 Suppl 1:96-100
references.pmid: 17445177
references.citation: J Immunol. 2009 Apr 15;182(8):5131-9
references.pmid: 19342694